OBJECTIVE: To examine associations between regional brain volumes and HIV DNA in peripheral CD14 cells (monocytes) among HIV-infected individuals naive to combination antiretroviral therapy (cART). DESIGN: A prospective study of HIV-infected Thai individuals who met Thai national criteria for cART initiation. Enrolment was stratified by HIV DNA in a blinded fashion. METHODS: CD14 cells were isolated from peripheral mononuclear cells to high purity (median 91.4% monocytes by flow cytometry), and HIV DNA was quantified by multiplex real-time PCR. Baseline regional brain volumes obtained by T1-weighted 1.5-Tesla MRI were compared between HIV DNA groups using analysis of covariance (ANCOVA). RESULTS: We studied 60 individuals with mean (SD) age of 34.7 (7.0) years, CD4 T-lymphocyte count of 232 (137) cells/μl and log10 plasma HIV RNA of 4.8 (0.73). Median (interquartile range, IQR) HIV DNA copy number per 10 CD14 cells was 54 (102). Using our previously determined optimal cut-point of 45 copies/10 cells for this cohort, a threshold value above which CD14 HIV DNA identified HIV-associated neurocognitive disorders (HANDs), we found that CD14 HIV DNA ≥ 45 copies/10 cells was associated with reduced volumes of the nucleus accumbens (P=0.021), brainstem (P=0.033) and total gray matter (P=0.045) independently of age, CD4 cell count and intracranial volume. CONCLUSION: HIV DNA burden in CD14 monocytes is directly linked to brain volumetric loss. Our findings implicate peripheral viral reservoirs in HIV-associated brain atrophy and support their involvement in the neuropathogenesis of HAND, underscoring the need for therapies that target these cells.
OBJECTIVE: To examine associations between regional brain volumes and HIV DNA in peripheral CD14 cells (monocytes) among HIV-infected individuals naive to combination antiretroviral therapy (cART). DESIGN: A prospective study of HIV-infected Thai individuals who met Thai national criteria for cART initiation. Enrolment was stratified by HIV DNA in a blinded fashion. METHODS:CD14 cells were isolated from peripheral mononuclear cells to high purity (median 91.4% monocytes by flow cytometry), and HIV DNA was quantified by multiplex real-time PCR. Baseline regional brain volumes obtained by T1-weighted 1.5-Tesla MRI were compared between HIV DNA groups using analysis of covariance (ANCOVA). RESULTS: We studied 60 individuals with mean (SD) age of 34.7 (7.0) years, CD4 T-lymphocyte count of 232 (137) cells/μl and log10 plasma HIV RNA of 4.8 (0.73). Median (interquartile range, IQR) HIV DNA copy number per 10 CD14 cells was 54 (102). Using our previously determined optimal cut-point of 45 copies/10 cells for this cohort, a threshold value above which CD14 HIV DNA identified HIV-associated neurocognitive disorders (HANDs), we found that CD14 HIV DNA ≥ 45 copies/10 cells was associated with reduced volumes of the nucleus accumbens (P=0.021), brainstem (P=0.033) and total gray matter (P=0.045) independently of age, CD4 cell count and intracranial volume. CONCLUSION: HIV DNA burden in CD14 monocytes is directly linked to brain volumetric loss. Our findings implicate peripheral viral reservoirs in HIV-associated brain atrophy and support their involvement in the neuropathogenesis of HAND, underscoring the need for therapies that target these cells.
Authors: Bruce Fischl; André van der Kouwe; Christophe Destrieux; Eric Halgren; Florent Ségonne; David H Salat; Evelina Busa; Larry J Seidman; Jill Goldstein; David Kennedy; Verne Caviness; Nikos Makris; Bruce Rosen; Anders M Dale Journal: Cereb Cortex Date: 2004-01 Impact factor: 5.357
Authors: J E Kaplan; D Hanson; M S Dworkin; T Frederick; J Bertolli; M L Lindegren; S Holmberg; J L Jones Journal: Clin Infect Dis Date: 2000-04 Impact factor: 9.079
Authors: R M Gulick; J W Mellors; D Havlir; J J Eron; C Gonzalez; D McMahon; D D Richman; F T Valentine; L Jonas; A Meibohm; E A Emini; J A Chodakewitz Journal: N Engl J Med Date: 1997-09-11 Impact factor: 91.245
Authors: Randy L Buckner; Denise Head; Jamie Parker; Anthony F Fotenos; Daniel Marcus; John C Morris; Abraham Z Snyder Journal: Neuroimage Date: 2004-10 Impact factor: 6.556
Authors: M Maj; P Satz; R Janssen; M Zaudig; F Starace; L D'Elia; B Sughondhabirom; M Mussa; D Naber; D Ndetei Journal: Arch Gen Psychiatry Date: 1994-01
Authors: Tae-Wook Chun; J Shawn Justement; Richard A Lempicki; Jun Yang; Glynn Dennis; Claire W Hallahan; Christina Sanford; Punita Pandya; Shuying Liu; Mary McLaughlin; Linda A Ehler; Susan Moir; Anthony S Fauci Journal: Proc Natl Acad Sci U S A Date: 2003-01-27 Impact factor: 11.205
Authors: Hernan Valdez; Elizabeth Connick; Kimberly Y Smith; Michael M Lederman; Ronald J Bosch; Ryung S Kim; Marty St Clair; Daniel R Kuritzkes; Harold Kessler; Lawrence Fox; Michelle Blanchard-Vargas; Alan Landay Journal: AIDS Date: 2002-09-27 Impact factor: 4.177
Authors: Katherine M Clifford; Vishal Samboju; Yann Cobigo; Benedetta Milanini; Gabriel A Marx; Joanna M Hellmuth; Howard J Rosen; Joel H Kramer; Isabel E Allen; Victor G Valcour Journal: J Acquir Immune Defic Syndr Date: 2017-11-01 Impact factor: 3.731
Authors: Marta Massanella; Wendy Bakeman; Pasiri Sithinamsuwan; James L K Fletcher; Nitiya Chomchey; Somporn Tipsuk; Thep Chalermchai; Jean-Pierre Routy; Jintanat Ananworanich; Victor G Valcour; Nicolas Chomont Journal: J Virol Date: 2019-12-12 Impact factor: 5.103
Authors: Brandon M Imp; Leah H Rubin; Phyllis C Tien; Michael W Plankey; Elizabeth T Golub; Audrey L French; Victor G Valcour Journal: J Infect Dis Date: 2016-10-26 Impact factor: 5.226
Authors: Jodi M Heaps; Pasiri Sithinamsuwan; Robert Paul; Sukalaya Lerdlum; Mantana Pothisri; David Clifford; Somporn Tipsuk; Stephanie Catella; Edgar Busovaca; James L K Fletcher; Benjamin Raudabaugh; Silvia Ratto-Kim; Victor Valcour; Jintanat Ananworanich Journal: J Neurovirol Date: 2015-01-21 Impact factor: 2.643
Authors: Rowan Saloner; Mariana Cherner; Jennifer E Iudicello; Robert K Heaton; Scott L Letendre; Ronald J Ellis Journal: J Acquir Immune Defic Syndr Date: 2020-10-01 Impact factor: 3.771
Authors: Asante R Kamkwalala; Xuzhi Wang; Pauline M Maki; Dionna W Williams; Victor G Valcour; Alexandra Damron; Phyllis C Tien; Kathleen M Weber; Mardge H Cohen; Erin E Sundermann; Vanessa J Meyer; Deborah M Little; Yanxun Xu; Leah H Rubin Journal: J Acquir Immune Defic Syndr Date: 2020-05-01 Impact factor: 3.771
Authors: Kalpana J Kallianpur; Maegen Walker; Mariana Gerschenson; Cecilia M Shikuma; Louie Mar A Gangcuangco; Lindsay Kohorn; Daniel E Libutti; Talia M Nir; Neda Jahanshad; Paul M Thompson; Robert Paul Journal: AIDS Res Hum Retroviruses Date: 2019-11-12 Impact factor: 2.205